The current status of trademark application 3551672 for REBLOZYL is Protection Granted.
The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.
| Application Number | 3551672 |
| Trademark Status | Protection Granted |
| Trademark Class | 5 |
| Application Date | 2017-02-14 |
| Proprietor Name | Celgene Corporation |
| Appropriate Office | IR DIVISION |
| State | STATE NOT SPECIFIED |
| Trademark Type | DEVICE |
| User Details | Proposed to be used |
| Goods And Services Details | [CLASS : 5] Pharmaceutical preparations for use in the treatment of beta thalassemia and myelodsplatic syndromes, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system. |
Similar trademarks found for this brand
| Brand | Class | Status |
|---|---|---|
| REBLOZYL | 5 | Protection Granted |
Common questions about REBLOZYL.